EE282 Financial Burden of Progression of Chronic Myeloid Leukemia (CML) Patients Who Failed Two or More Tyrosine Kinase Inhibitors Treatment in the Brazilian Private Market Perspective
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.583
https://www.valueinhealthjournal.com/article/S1098-3015(23)00683-6/fulltext
Title :
EE282 Financial Burden of Progression of Chronic Myeloid Leukemia (CML) Patients Who Failed Two or More Tyrosine Kinase Inhibitors Treatment in the Brazilian Private Market Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)00683-6&doi=10.1016/j.jval.2023.03.583
First page :
Section Title :
Open access? :
No
Section Order :
10068